Abbott reported second-quarter 2026 results showing strong top-line growth and an improved earnings outlook for the year. The healthcare company said reported sales rose 13.0% in the quarter, while comparable sales increased 4.8%, pointing to continued business momentum.
On the bottom line, Abbott posted GAAP diluted earnings per share of $0.53 for the quarter. Adjusted diluted EPS came in at $1.31, giving investors a clearer view of underlying operating performance.
The company also raised its full-year EPS guidance, a sign that management expects stronger earnings performance over the remainder of 2026. That updated forecast follows the solid second-quarter showing and suggests confidence in Abbott’s current business trends.
Abbott’s latest report highlights a quarter defined by revenue growth, steady comparable sales gains and improved profit expectations. With second-quarter results now in hand, the company enters the second half of 2026 with a more upbeat earnings outlook.
